Pathologic findings in dogs with shock induced by intravenous administration of heartworm extract

American Journal of Veterinary Research

Volumn 59, Issue 11, 1998, Pages 1417-1422

  Kitoh, Katsuya ^a   Kitagawa, Hitoshi ^a   Sasaki, Yoshihide ^a  

^a GIFU UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIFILARIAL AGENT;

ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DIROFILARIA IMMITIS; DOG; FEMALE; HISTOPATHOLOGY; HYALINE DEGENERATION; LIVER NECROSIS; MALE; NONHUMAN; PATHOPHYSIOLOGY; SHOCK; VETERINARY MEDICINE;

ANAPHYLAXIS; ANIMALS; DIROFILARIA IMMITIS; DIROFILARIASIS; DOG DISEASES; DOGS; FEMALE; LIVER; MALE; MYOCARDIUM; SHOCK; SPLANCHNIC CIRCULATION; TISSUE EXTRACTS; VASOCONSTRICTION;

EID: 0031795934     PISSN: 00029645     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Kitoh K, Watoh K, Chaya K, et al. Clinical, hematologic, and biochemical findings in dogs after induction of shock by injection of heartworm extract. Am J Vet Res 1994;55:1535-1541.
2. Kitoh K, Watoh K, Kitagawa H, et al. Blood coagulopathy in dogs with shock induced by injection of heartworm extract. Am J Vet Res 1994;55:1542-1547.
3. Boreham PFL, Atwell RB. Adverse drug reactions in the treatment of filarial parasites: haematological, biochemical, immunological and pharmacological changes in Dirofilaria immitis infected dogs treated with diethylcarbamazine. Int J Parasitol 1983;13: 547-556.
4. Garlick NL. Adverse drug effects precipitated by microfilariae of Dirofilaria immitis. Clin Toxicol 1976;9:981-992.
5. Palumbo NE, Desowitz RS, Perri SF. Observations on the adverse reaction to diethylcarbamazine in Dirofilaria immitis-infected dogs. Tropenmed Parasitol 1981;32:115-118.
6. Powers KG, Parbuoni EL, Furrow RD. Dirofilaria immitis: I. Adverse reactions associated with diethylcarbamazine therapy in microfilaremic dogs. In: Morgan HC, Otto GF, Jackson RF, et al, eds. Proceedings of the heartworm symposium 1980. Edwardsville, Kan: Veterinary Medical Publishing Co, 1981;108-116.
7. Sasaki Y, Kitagawa H, Ishihara K. Clinical application of milbemycin D as a prophylactic agent against Dirofilaria immitis infection in dogs: clinical findings in dogs with shock-like reaction. Jpn J Vet Sci 1986;48:1207-1214.
8. Hardie EM, Rawlings CA. Septic shock. Part I. Pathophysiology. Compend Contin Educ Pract Vet 1983;5:369-377.
9. Mueller DL, Noxon JO. Anaphylaxis: pathophysiology and treatment. Compend Contin Educ Pract Vet 1990;12:157-171.
10. Furrow RD, Powers KG, Parbuoni EL. Dirofilaria immitis: II. Gross and microscopic hepatic changes associated with diethylcarbamazine citrate (DEC) therapy in dogs. In: Morgan HC, Otto GF, Jackson RF, et al, eds. Proceedings of the heartworm symposium 1980. Edwardsville, Kan: Veterinary Medical Publishing Co, 1981;117-121.
11. Sutton RH, Atwell RB, Boreham PFL. Liver changes, following diethylcarbamazine administration, in microfilaremic dogs infected with Dirofilaria immitis. Vet Pathol 1985;22:177-183.
12. Sasaki Y, Kitagawa H, Ishihara K, et al. Clinical application of milbemycin D as a prophylactic agent against Dirofilaria immitis infection in dogs: pathological findings following administration. Jpn J Vet Sci 1988;50:977-984.
13. Winter H. The pathology of canine dirofilariasis. Am J Vet Res 1959;20:366-371.
14. Hirth RS, Huizinga HW, Nielsen SW. Dirofilariasis in Connecticut dogs. J Am Vet Med Assoc 1966;148:1508-1516.
15. Schertel ER, Muir WW. Shock: pathophysiology, monitoring, and therapy. In: Kirk RW, ed.Current veterinary therapy X. Small animal practice. Philadelphia: WB Saunders Co, 1989;316-330.
16. Weeren FR, Muir WW III. Clinical aspects of septic shock and comprehensive approaches to treatment in dogs and cats. J Am Vet Med Assoc 1992;200:1859-1870.
17. Guntheroth WG, Kawabori I. The contribution of splanchnic pooling to endotoxin shock in the dog. Circ Res 1977;41: 467-472.
18. Wagner EM, Mitzner WA, Bleecker ER. Peripheral circulatory alterations in canine anaphylactic shock. Am J Physiol 1986;251: H934-H940.
19. Knisely MH, Harding F, Debacker H. Hepatic sphincters. Science 1957;125:1023-1026.
20. Okabayashi A. Lesions in the heart. In: Miyaji T, ed. Clinical histopathology. Tokyo: Kyorin Shoin Co Ltd, 1969;1-22.
21. Ohneta G. Lesions in the vessels. In: Miyaji T, ed. Clinical histopathology. Tokyo: Kyorin Shoin Co Ltd, 1969;23-70.
22. Shibayama Y. Endotoxin and liver injury. Metab Dis 1989;26:441-451.
23. Sato T, Shinzawa H, Abe Y, et al. Inhibition of Corynebacterium parvum-primed and lipopolysaccharide-induced hepatic necrosis in rats by selective depletion of neutrophils using a monoclonal antibody. J Leukoc Biol 1993;53:144-150.
24. Granger DN. Role of xanthine oxidase and granulocytes in ischemia-reperfusion injury. Am J Physiol 1988;255:H1269-H1275.
25. Balk RA, Jacobs RF, Tryka AF, et al. Effects of ibuprofen on neutrophil function and acute lung injury in canine endotoxin shock. Crit Care Med 1988;16:1121-1127.
26. Myrvold HE, Brandberg Å. Microembolism in experimental septic shock. Eur Surg Res 1977;9:34-37.
27. Pinckard RN, Halonen M, Palmer JD, et al. Intravascular aggregation and pulmonary sequestration of platelets during IgE-induced systemic anaphylaxis in the rabbit: abrogation of lethal anaphylactic shock by platelet depletion. J Immunol 1977;119:2185-2193.